Gallic acid induces apoptosis in 3T3-L1 pre-adipocytes via a fas- and mitochondrial-mediated pathway

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 18, 2007, Pages 7359-7365

  Hsu, Chin Lin ^a   Lo, Wen Hsieh ^a   Yen, Gow Chin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

3T3 L1 pre adipocytes; Apoptosis; Gallic acid

Indexed keywords

CASPASE; FAS ANTIGEN; GALLIC ACID;

ADIPOCYTE; ANIMAL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL STRAIN 3T3; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; MITOCHONDRION; MOUSE; PHYSIOLOGY; ULTRASTRUCTURE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASES; CELL DIVISION; GALLIC ACID; MICE; MITOCHONDRIA;

EID: 34848898720     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf071223c     Document Type: Article

References (31)

1. Kopelman, P. G. Obesity as a medical problem. Nature (London, U.K.) 2000, 404, 635-643.
2. Furuyashiki, T.; Nagayasu, H.; Aoki, Y.; Bessho, H.; Hashimoto, T.; Kanazawa, K.; Ashida, H. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells. Biosci., Biotechnol., Biochem. 2004, 68, 2353-2359.
3. Evans, W. D.; Finkelstein, E. A.; Kamerow, D. B.; Renaud, J. M. Public perceptions of childhood obesity. Am. J. Prev. Med. 2005, 28, 26-32.
4. Asayama, K.; Nakane, T.; Dobashi, K.; Kodera, K.; Hayashibe, H.; Uchida, N.; Nakazawa, S. Effect of obesity and troglitazone on expression of two glutathione peroxidases: Cellular and extracellular types in serum, kidney, and adipose tissue. Free Radical Res. 2001, 34, 337-347.
5. Carmiel-Haggai, M.; Cederbaum, A. I.; Nieto, N. A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB J. 2005, 19, 136-138.
6. Benavente-Garcia, O.; Castillo, J.; Marin, F. R.; Del Rio, J. A. Uses and properties of citrus flavonoids. J. Agric. Food Chem. 1997, 45, 4505-4515.
7. Galati, G.; O'Brien, P. J. Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Radical Biol. Med. 2004, 37, 287-303.
8. Ohno, Y.; Fukuda, K.; Takemura, G.; Toyota, M.; Watanabe, M.; Yasuda, N.; Xinbin, O.; Maruyama, R.; Akao, S.; Gotou, K.; Fujivara, T.; Fujivara, H. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999, 10, 845-851.
9. Yoshioka, K.; Kataoka, T.; Hayashi, T.; Hasegawa, M.; Ishi, Y.; Hibasami, H. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol. Rep. 2000, 6, 1221-1223.
10. Johnstone, R. W.; Ruefli, A. A.; Lowe, S. W. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002, 108, 153-164.
11. Alvarez, S.; Drane, P.; Meiller, A.; Bras, M.; Deguin-Chambon, V.; Bouvard, V.; May, E. A comprehensive study of p53 transcriptional activity in thymus and spleen of γ-irradiated mouse: High sensitivity of genes involved in the two main apoptotic pathways. Int. J. Radiat. Biol. 2006, 82, 761-770.
12. Vermeulen, K.; Van Bockstaele, D. R.; Berneman, Z. N. Apoptosis: Mechanisms and relevance in cancer. Ann. Hematol. 2005, 84, 627-639.
13. Zamzami, N.; Metivier, D.; Kroemer, G. Quantitation of mitochondrial transmembrane potential in cells and isolated mitochondria. Methods Enzymol. 2000, 322, 208-213.
14. Wang, Y. W.; Jones, P. J. Conjugated linolic acid and obesity control: Efficacy and mechanisms. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 941-955.
15. Hsu, C. L.; Huang, S. L.; Yen, G. C. Inhibitory effect of phenolic acids on proliferation of 3T3-L1 preadipocytes in relation to their antioxidant activity. J. Agric. Food Chem. 2006, 54, 4191-4197.
16. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
17. Hunt, A.; Evan, G. Apoptosis. Till death us do part. Science (Washington, DC, U.S.) 2001, 293, 1784-1785.
18. Thornberry, N. A.; Rano, T. A.; Peterson, E. P.; Rasper, D. M.; Timkey, T.; Garcia-Calvo, M.; Houtzager, V. M.; Nordstrom, P. A.; Roy, S.; Vaillancourt, J. P.; Chapman, K. T.; Nicholson, D. W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 1997, 272, 17907-17911.
19. Nagata, S.; Golstein, P. The Fas death factor. Science (Washington, DC, U.S.) 1995, 267, 1449-1456.
20. Shen, Y.; White, E. p53-Dependent apoptosis pathways. Adv. Cancer Res. 2001, 82, 55-84.
21. Merry, D. E.; Korsmeyer, S. J. Bcl-2 gene family in the nervous system. Ann. Rev. Neurosci. 1997, 20, 245-267.
22. Cory, S.; Adams, J. M. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2002, 2, 647-656.
23. Thornberry, N. A.; Lazebnik, Y. Caspases: Enemies within. Science (Washington, DC, U.S.) 1998, 281, 1312-1316.
24. Green, D. R.; Reed, J. C. Mitochondria and apoptosis. Science (Washington, DC, U.S.) 1998, 281, 1309-1312.
25. Debatin, K. M.; Krammer, P. H. Death receptors in chemotherapy and cancer. Oncogene 2004, 23, 2950-2966.
26. Rosato, R. R.; Grant, S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol. Ther. 2003, 2, 30-37.
27. Mork, C. N.; Faller, D. V.; Spanjaard, R. A. A mechanistic approach to anticancer therapy: Targeting the cell cycle with histone deacetylase inhibitors. Curr. Pharm. Des. 2005, 11, 1091-1104.
28. Yang, W. M.; Yao, Y. L.; Sun, J. M.; Davie, J. R.; Seto, E. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J. Biol. Chem. 1997, 272, 28001-28007.
29. Gu, W.; Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90, 595-606.
30. WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 6791-6796.
31. Joung, K. E.; Kim, D. K.; Sheen, Y. Y. Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells. Arch. Pharm. Res. 2004, 27, 640-645.